Conventional approaches to the treatment of recurrent mantle cell lymphoma (MCL) yield unsatisfactory results. We describe a patient with recurrent MCL in leukemic phase refractory to chemotherapy who was successfully treated with allogeneic bone marrow transplantation. At last follow-up 1 year post-transplant, the patient was in complete remission and had limited chronic graft-versus-host disease.
机构:
Washington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USAWashington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USA
Adkins, D
Brown, R
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USAWashington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USA
Brown, R
Goodnough, LT
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USAWashington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USA
Goodnough, LT
Khoury, H
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USAWashington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USA
Khoury, H
Popovic, W
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USAWashington Univ, Sch Med, Dept Internal Med, Div Bone Marrow Transplantat, St Louis, MO 63110 USA